Amber Therapeutics Holdings Limited
Amber Therapeutics is pioneering adaptive neuromodulation therapies to treat mixed urinary incontinence in women. Their innovative Picostim™ System targets the pudendal nerve, offering personalized treatment that adapts to individual physiological responses.
Founded: 18 Dec 2020
Industries:
72110 - Research and experimental development on biotechnology
Website: amber-tx.com
Location: Didcot
Products & Services
• adaptive neuromodulation therapy
• adaptive therapy
• biotechnology
• medical device
• neuromodulation
• picostim™ system
• therapeutics
• urinary incontinence
Financial Snapshot
Cash in Bank
Turnover
EBITDA
Gross Profit
Total Liabilities
Employees
Unlock financial data with Pro Start Free Trial →
People
Officers
6
Shareholders
49
Controllers (PSC)
2
Liliane Chamas
Director • British,canadian • Lives in United Kingdom • Born in Oct 1986
Aidan Harold Winston Crawley
Director • British • Lives in England • Born in Oct 1983
Yen-min Kevin Chu
Director • Canadian • Lives in United States • Born in Feb 1989
Caroline Butler
Director • Irish • Lives in Ireland • Born in Feb 1980
Tiffany Le
Director • American • Lives in United States • Born in Jun 1990
Registered Office Address
Unit 1 Tech Foundry 2
Curie Avenue
Didcot
OX11 0QQ
England
Basic Information
LTD
18 Dec 2020
ENGLAND WALES
Yes
Industry Classification
72110
Company Attributes
N/A
N/A
N/A
N/A
Summary
8
Officers
2
PSCs
0
Filings